Next Article in Journal
Decontaminative Properties of Cold Atmospheric Plasma Treatment on Collagen Membranes Used for Guided Bone Regeneration
Previous Article in Journal
Evaluation of Implant Surface Modification with Nanohydroxyapatite Associated with the Use of L-PRF: In Vivo Study in Rats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Bioprinted 3D Bionic Scaffolds with Pancreatic Islets as a New Therapy for Type 1 Diabetes—Analysis of the Results of Preclinical Studies on a Mouse Model

by
Marta Klak
1,2,
Michał Wszoła
1,2,*,
Andrzej Berman
1,2,
Anna Filip
1,
Anna Kosowska
3,
Joanna Olkowska-Truchanowicz
4,
Michał Rachalewski
1,
Grzegorz Tymicki
1,
Tomasz Bryniarski
1,
Marta Kołodziejska
1,
Tomasz Dobrzański
2,
Dominika Ujazdowska
1,
Jarosław Wejman
5,
Izabela Uhrynowska-Tyszkiewicz
4 and
Artur Kamiński
4
1
Foundation of Research and Science Development, 01-793 Warsaw, Poland
2
Polbionica Sp. z o.o., 01-793 Warsaw, Poland
3
Chair and Department of Histology and Embryology, Medical University of Warsaw, 02-004 Warsaw, Poland
4
Department of Transplantology and Central Tissue Bank, Medical University of Warsaw, 02-004 Warsaw, Poland
5
Center for Pathomorphological Diagnostics Sp. z o.o., 01-496 Warsaw, Poland
*
Author to whom correspondence should be addressed.
J. Funct. Biomater. 2023, 14(7), 371; https://doi.org/10.3390/jfb14070371
Submission received: 9 June 2023 / Revised: 7 July 2023 / Accepted: 8 July 2023 / Published: 14 July 2023

Abstract

Recently, tissue engineering, including 3D bioprinting of the pancreas, has acquired clinical significance and has become an outstanding potential method of customized treatment for type 1 diabetes mellitus. The study aimed to evaluate the function of 3D-bioprinted pancreatic petals with pancreatic islets in the murine model. A total of 60 NOD-SCID (Nonobese diabetic/severe combined immunodeficiency) mice were used in the study and divided into three groups: control group; IsletTx (porcine islets transplanted under the renal capsule); and 3D bioprint (3D-bioprinted pancreatic petals with islets transplanted under the skin, on dorsal muscles). Glucose, C-peptide concentrations, and histological analyses were performed. In the obtained results, significantly lower mean fasting glucose levels (mg/dL) were observed both in a 3D-bioprint group and in a group with islets transplanted under the renal capsule when compared with untreated animals. Differences were observed in all control points: 7th, 14th, and 28th days post-transplantation (129, 119, 118 vs. 140, 139, 140; p < 0.001). Glucose levels were lower on the 14th and 28th days in a group with bioprinted petals compared to the group with islets transplanted under the renal capsule. Immunohistochemical staining indicated the presence of secreted insulin-living pancreatic islets and neovascularization within 3D-bioprinted pancreatic petals after transplantation. In conclusion, bioprinted bionic petals significantly lowered plasma glucose concentration in studied model species.
Keywords: diabetes; pancreas islets; 3D bioprinting; glucose; xenotransplantation; bionic scaffold diabetes; pancreas islets; 3D bioprinting; glucose; xenotransplantation; bionic scaffold

Share and Cite

MDPI and ACS Style

Klak, M.; Wszoła, M.; Berman, A.; Filip, A.; Kosowska, A.; Olkowska-Truchanowicz, J.; Rachalewski, M.; Tymicki, G.; Bryniarski, T.; Kołodziejska, M.; et al. Bioprinted 3D Bionic Scaffolds with Pancreatic Islets as a New Therapy for Type 1 Diabetes—Analysis of the Results of Preclinical Studies on a Mouse Model. J. Funct. Biomater. 2023, 14, 371. https://doi.org/10.3390/jfb14070371

AMA Style

Klak M, Wszoła M, Berman A, Filip A, Kosowska A, Olkowska-Truchanowicz J, Rachalewski M, Tymicki G, Bryniarski T, Kołodziejska M, et al. Bioprinted 3D Bionic Scaffolds with Pancreatic Islets as a New Therapy for Type 1 Diabetes—Analysis of the Results of Preclinical Studies on a Mouse Model. Journal of Functional Biomaterials. 2023; 14(7):371. https://doi.org/10.3390/jfb14070371

Chicago/Turabian Style

Klak, Marta, Michał Wszoła, Andrzej Berman, Anna Filip, Anna Kosowska, Joanna Olkowska-Truchanowicz, Michał Rachalewski, Grzegorz Tymicki, Tomasz Bryniarski, Marta Kołodziejska, and et al. 2023. "Bioprinted 3D Bionic Scaffolds with Pancreatic Islets as a New Therapy for Type 1 Diabetes—Analysis of the Results of Preclinical Studies on a Mouse Model" Journal of Functional Biomaterials 14, no. 7: 371. https://doi.org/10.3390/jfb14070371

APA Style

Klak, M., Wszoła, M., Berman, A., Filip, A., Kosowska, A., Olkowska-Truchanowicz, J., Rachalewski, M., Tymicki, G., Bryniarski, T., Kołodziejska, M., Dobrzański, T., Ujazdowska, D., Wejman, J., Uhrynowska-Tyszkiewicz, I., & Kamiński, A. (2023). Bioprinted 3D Bionic Scaffolds with Pancreatic Islets as a New Therapy for Type 1 Diabetes—Analysis of the Results of Preclinical Studies on a Mouse Model. Journal of Functional Biomaterials, 14(7), 371. https://doi.org/10.3390/jfb14070371

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop